What is the starting dose of CD/LD, and what is the range of CD/LD formulations available for PD? Why does the eventual onset of motor fluctuations and “wearing off” observed over time present opportunities for scored, fractionated dose formulations?

What is the starting dose of CD/LD, and what is the range of CD/LD formulations available for PD? Why does the eventual onset of motor fluctuations and “wearing off” observed over time present opportunities for scored, fractionated dose formulations?

What is the initial starting dose of carbidopa/levodopa, and what is the range of CD/LD formulations currently available for PD? Why does the eventual onset of motor fluctuations and “wearing off” observed over time present opportunities for consideration of scored, fractionated dose formulations of CD/LD?


Created by

CMEducation Resources iQ&A Parkinson’s Disease (PD) Medical Intelligence Zone

Related Presenters

John Morgan, MD, PhD

John Morgan, MD, PhD

Professor and DirectorMovement & Memory Disorder ProgramsDepartment of NeurologyMedical College of GeorgiaAugusta UniversityAugusta, Georgia